Home › Funds › Blue Owl Capital Holdings LP › IRD
Blue Owl Capital Holdings LP position in IRD
OPUS GENETICS INC · Health Care
Blue Owl Capital Holdings LP reported holding 969,605 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.88% of its reported portfolio and ranking #19 among its reported holdings. Blue Owl Capital Holdings LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's IRD position evolved
Blue Owl Capital Holdings LP first disclosed a stake in IRD in Q3 2026 at 969,605 shares (US$4.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 969.61K | $4.69M | New |
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 74 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- Caligan Partners LP 6.08M sh · $24.98M · Q2 2026
- BIOS Capital Management, LP 3.68M sh · $15.14M · Q2 2026
- Boxer Capital Management, LLC 2.81M sh · $11.57M · Q2 2026
- Trails Edge Capital Partners, LP 2.74M sh · $11.28M · Q2 2026
- GREAT POINT PARTNERS LLC 1.97M sh · $8.10M · Q2 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- Propel Bio Management, LLC 270.04K sh · $1.31M · Q3 2026
- Mink Brook Asset Management LLC 161.21K sh · $662.55K · Q2 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held IRD?
Blue Owl Capital Holdings LP has disclosed IRD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Blue Owl Capital Holdings LP's current position in IRD?
As of Q3 2026, Blue Owl Capital Holdings LP holds 969.61K shares of IRD (OPUS GENETICS INC), valued at $4.69M, representing 0.88% of its reported portfolio and ranking #19.
Has Blue Owl Capital Holdings LP been buying or selling IRD?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP newly opened its position in IRD.
Which other funds hold IRD?
Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.